" class="no-js "lang="en-US"> Sherlock Biosciences - Medtech Alert
Monday, December 11, 2023
Sherlock Biosciences | MTA

Sherlock Biosciences

About Sherlock Biosciences

Sherlock Biosciences
Sherlock Biosciences is developing products that will empower people to access answers and have more control over their health decisions. Through our engineering biology tools, CRISPR-based SHERLOCK™ and synthetic biology-based INSPECTR™, we are bringing together the accuracy of PCR with the convenience and simplicity of antigen tests for molecular diagnostics at the point-of-need. SHERLOCK and INSPECTR can be used in virtually any setting without complex instrumentation, making it well suited for use in the home and in low resource settings, opening up a wide range of potential applications in areas including infectious disease, early detection of cancer, treatment monitoring, and precision medicine. In 2020 the company made history with the first FDA-authorized use of CRISPR technology.

Related Story

Sherlock Biosciences Appoints Maurice Exner as Chief Scientific Officer

April 13 2023

Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced that […]